You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

castration-resistant, metastatic prostate cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

Recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • pTVG-HP
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 21, 2022

Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

Recruiting
  • Castration Resistant Metastatic Prostate Cancer
  • Testosterone cypionate
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University/Sidney Kimmel Cancer Center
Aug 4, 2022

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone acetate)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Oct 23, 2023

Prostatic Tumors, Metastatic Castration-Resistant Prostate Cancer Trial (MK-5684, Dexamethasone, Fludrocortisone)

Not yet recruiting
  • Prostatic Neoplasms
  • Metastatic Castration-Resistant Prostate Cancer
  • (no location specified)
Nov 13, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Bortezomib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 7, 2023

Metastatic Castration-resistant Prostate Cancer Trial (ONCT-534)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Jun 15, 2023

Castration-Resistant Prostatic Cancer Trial ([Lu-177]-PNT2002)

Available
  • Castration-Resistant Prostatic Cancer
  • (no location specified)
Sep 11, 2023

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

Advanced Prostate Cancer Trial (HRS-5041)

Not yet recruiting
  • Advanced Prostate Cancer
  • (no location specified)
Jul 5, 2023

Metastatic Castration Resistant Prostate Cancer Trial in London (IMU-935)

Recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • London, United Kingdom
    Institute of Cancer Research
Jan 31, 2023

Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy

Recruiting
  • PSMA-positive Metastatic Castration-resistant Prostate Cancer Treated With PSMA Radionuclide Therapy
  • PSMA radionuclide therapy
  • Dallas, Texas
    Methodist Dallas Medical Center
Aug 9, 2023

Metastatic Castration-resistant Prostate Cancer Trial in United States (BMS-986460)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Palo Alto, California
  • +7 more
Oct 10, 2023

Prostate Cancer Trial in Beijing, Nanjing (QLH12016)

Not yet recruiting
  • Prostate Cancer
  • Beijing, Beijign, China
  • +1 more
Jul 25, 2023

Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in San Francisco

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • +3 more
  • San Francisco, California
    University of California, San Francisco
Mar 1, 2023

Metastatic Castration-resistant Prostate Cancer Trial in Salt Lake City (Enfortumab vedotin)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Enfortumab vedotin
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 24, 2023

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Tumors Trial (MK-5684, Dexamethasone, Fludrocortisone

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer (mCRPC)
    • Prostatic Neoplasms
    • (no location specified)
    Nov 21, 2023

    Darolutamide, Enzalutamide and Apalutamide and How Well These

    Not yet recruiting
    • Non-metastatic Castration-resistant Prostate Cancer
    • Whippany, New Jersey
      Bayer
    Aug 25, 2023

    Metastasis Castration Resistant Prostate Cancer(mCRPC) Trial (HS-20093)

    Not yet recruiting
    • Metastasis Castration Resistant Prostate Cancer(mCRPC)
    • (no location specified)
    Aug 14, 2023

    Hormone-refractory Prostate Cancer Trial (AMX-500)

    Not yet recruiting
    • Hormone-refractory Prostate Cancer
    • (no location specified)
    Aug 11, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T
    • Oklahoma City, Oklahoma
      Stephenson's Cancer Center
    Mar 28, 2023

    Metastatic Castration-resistant Prostate Cancer Trial (Disitamab Vedotin(RC48-ADC))

    Not yet recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Disitamab Vedotin（RC48-ADC）
    • (no location specified)
    Jul 13, 2023

    Medicines Called Enzalutamide and Abiraterone in People With

    Not yet recruiting
    • Prostatic Neoplasms, Castration-Resistant
    • New York, New York
      Pfizer Inc
    Jul 21, 2023

    Prostate Cancer, Prostate Cancer Metastatic Trial in La Jolla (Abivertinib, Abiraterone)

    Recruiting
    • Prostate Cancer
    • Prostate Cancer Metastatic
    • La Jolla, California
    • +1 more
    Feb 2, 2023

    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

    Not yet recruiting
    • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
    • Sipuleucel-T Injection
    • (no location specified)
    Nov 10, 2023